Toggle navigation
Home
Medical
SGLT-2 Inhibitors, GLP1-RAs Show Cardiorenal Event Prevention
1-2-2022
Medical
https://www.medscape.com/cx/rssfeeds/2700.xml
93
Meta-analysis of 23 cardiovascular outcome trials of antidiabetic agents shows that SGLT-2 inhibitors and GLP-1RAs clearly outperform DPP-4 inhibitors. First Look
Share
Tweet
+1
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Related News
Many Young Kids With COVID Show No Symptoms of the Disease
Cancer patients facing housing instability show greater...
5 ways to show your office manager they’re a rockstar
East of England Dentistry Show – two weeks to go!
How do different social settings impact super-spreading...
Irish Dentistry Show – two weeks to go!
Irish Dentistry Show – don’t miss Avijit Banerjee
Scottish Dental Show 2022
No One-Size-Fits-All Artificial Intelligence Approach...
No one-size-fits-all AI approach works for prevention,...